Korea Clinical Trials Hub

Investigators

Basic Information

Investigator: Anhye Kim

Country: South Korea

Affiliation: CHA Bundang Medical Center CHA University

Specialty: Clinical Pharmacology

Clinical Trial History

Clinical Trial Experience: 11 year

Multicenter Clinical Trial Performance Status: Yes

IND Submission History (Count): 0 Count

Related Papers/Publications (Count): 0 Count

Clinical Trial Details

Total 27

Trial Title: A Study to Evaluate Drug-drug Interactions and Safety Between BR3006-1, BR3006-2, and BR3006-3 in Healthy Volunteers

Therapy Area: Metabolic Disorders

Indication(s): Type 2 Diabetes

Investigator’s Role: Contact Person

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Clinical Study to Compare and Evaluate the Pharmacokinetics and Safety of Vildagliptin Sr and Galvus Tab. And Evaluate the Food Effect on the Pharmacokinetics of Vildagliptin Sr in Healthy Adult Volunteers

Therapy Area: Metabolic Disorders

Indication(s): Type 2 Diabetes

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Therapy Area: Infectious Disease

Indication(s): Cholera

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: A First-in-human, Single- and Multiple-ascending Dose Study of YH35995 in Healthy Adult Male Participants

Therapy Area: Metabolic Disorders

Indication(s): Gaucher Disease Type III

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Ongoing, recruiting

Trial Title: A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Therapy Area: Oncology

Indication(s): Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Investigator’s Role: Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Therapy Area: Oncology

Indication(s): Prostate Cancer

Investigator’s Role: Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers

Therapy Area: Respiratory

Indication(s): Idiopathic Pulmonary Fibrosis

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Pharmacokinetics and Safety of DWP14012 Tablet a and Tablet B in Healthy Volunteers (III)

Therapy Area: Gastrointestinal

Indication(s): Gastritis

Investigator’s Role: Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

Therapy Area: Metabolic Disorders

Indication(s): Type 2 Diabetes

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

Therapy Area: Genito Urinary System

Indication(s): Renal Failure

Investigator’s Role: Contact Person

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Multiple Ascending Dose, Phase Ib Clinical Study of LCB01-0371

Therapy Area: Infectious Disease

Indication(s): Methicillin-Resistant Staphylococcus aureus (MRSA) Infections

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Multiple Ascending Dose, Phase Ib Clinical Study of LCB01-0371

Therapy Area: Infectious Disease

Indication(s): Vancomycin-Resistant Enterococcus faecium Infections

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Multiple Ascending Dose, Phase Ib Clinical Study of LCB01-0371

Therapy Area: Infectious Disease

Indication(s): Mycobacterium tuberculosis Infections

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Multiple Ascending Dose, Phase Ib Clinical Study of LCB01-0371

Therapy Area: Respiratory

Indication(s): Streptococcal Pneumonia

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Therapy Area: Metabolic Disorders

Indication(s): Type 2 Diabetes

Investigator’s Role: Contact Person; Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Clinical Trial to Evaluate the Pharmacokinetic Properties and Safety of YHD1119 Single Oral Administration in Patients with Renal Impairment and Healthy People

Therapy Area: Central Nervous System

Indication(s): Peripheral Neuropathic Pain

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Clinical Trial to Evaluate the Pharmacokinetic Properties and Safety of YHD1119 Single Oral Administration in Patients with Renal Impairment and Healthy People

Therapy Area: Genito Urinary System

Indication(s): Renal Failure

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Therapy Area: Musculoskeletal Disorders

Indication(s): Post Menopausal Osteoporosis

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Therapy Area: Musculoskeletal Disorders

Indication(s): Bone Disorders

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Therapy Area: Musculoskeletal Disorders

Indication(s): Osteoporosis

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between BR1015-1 And BR1015-2 In Healthy Volunteers

Therapy Area: Cardiovascular

Indication(s): Idiopathic (Essential) Hypertension

Investigator’s Role: Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Drug-drug Interactions and Safety among P-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Therapy Area: Gastrointestinal

Indication(s): Unspecified Gastrointestinal Disorders

Investigator’s Role: Contact Person

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Drug-drug Interactions and Safety among P-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Therapy Area: Gastrointestinal

Indication(s): Reflux Esophagitis (Gastroesophageal Reflux Disease)

Investigator’s Role: Contact Person

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Therapy Area: Gastrointestinal

Indication(s): Reflux Esophagitis (Gastroesophageal Reflux Disease)

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Therapy Area: Gastrointestinal

Indication(s): Gastric Ulcers

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Therapy Area: Gastrointestinal

Indication(s): Corrosive Esophagitis (Erosive Esophagitis)

Investigator’s Role: Co-Author

Trial Phase: Phase I

Trial Status: Completed

Trial Title: A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

Therapy Area: Hormonal Disorders

Indication(s): Male Hypogonadism

Investigator’s Role: Principal Investigator

Trial Phase: Phase I

Trial Status: Completed

ViewList